General Information of the Compound
| Compound ID |
CP0541406
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[(1R)-1-[2-(3,5-dichlorophenyl)-3-oxo-1,4-diazaspiro[4.5]dec-1-en-4-yl]-4,4-dimethylpentyl]-N-(2H-tetrazol-5-ylmethyl)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H35Cl2N7O2
|
||||||||||||||||||
| Molecular Weight |
596.563
|
||||||||||||||||||
| Canonical SMILES |
CC(C)(C)CC[C@@H](N1C(=O)C(=NC11CCCCC1)c1cc(Cl)cc(Cl)c1)c1ccc(cc1)C(=O)NCc1nn[nH]n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H35Cl2N7O2/c1-29(2,3)14-11-24(19-7-9-20(10-8-19)27(40)33-18-25-35-37-38-36-25)39-28(41)26(21-15-22(31)17-23(32)16-21)34-30(39)12-5-4-6-13-30/h7-10,15-17,24H,4-6,11-14,18H2,1-3H3,(H,33,40)(H,35,36,37,38)/t24-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
OUDFNHMFVLVOMJ-XMMPIXPASA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01473, Glucagon receptor
Protein ID: PT01356, Glucagon-like peptide 1 receptor